CR11240A - Nuevos compuestos anti microbianos, su sintesis y su uso para el tratamiento de infecciones en mamiferos - Google Patents

Nuevos compuestos anti microbianos, su sintesis y su uso para el tratamiento de infecciones en mamiferos

Info

Publication number
CR11240A
CR11240A CR11240A CR11240A CR11240A CR 11240 A CR11240 A CR 11240A CR 11240 A CR11240 A CR 11240A CR 11240 A CR11240 A CR 11240A CR 11240 A CR11240 A CR 11240A
Authority
CR
Costa Rica
Prior art keywords
infections
mammals
synthesis
treatment
new anti
Prior art date
Application number
CR11240A
Other languages
English (en)
Inventor
Mollmann Ute
Makarov Vadim
Stewart T Cole
Original Assignee
Leibniz Inst Fur Naturstoff Fo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leibniz Inst Fur Naturstoff Fo filed Critical Leibniz Inst Fur Naturstoff Fo
Publication of CR11240A publication Critical patent/CR11240A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/08—1,3-Thiazines; Hydrogenated 1,3-thiazines condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere a nuevos compuestos antimicrobianos, a su sintesis y a su uso para el tratamiento de infecciones en mamiferos. La presente invencion esta dirigida a la generacion de nuevos compuestos con actividad contra mycobaterias como nuevos farmacos potenciales contra la tuberculosis para superar problemas concernientes a la resistencia y a la intolerancia a farmacos.
CR11240A 2007-07-16 2010-01-27 Nuevos compuestos anti microbianos, su sintesis y su uso para el tratamiento de infecciones en mamiferos CR11240A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07013899A EP2020406A1 (en) 2007-07-16 2007-07-16 New antimicrobial compounds, their synthesis and their use for treatment of mammalian infection

Publications (1)

Publication Number Publication Date
CR11240A true CR11240A (es) 2010-05-19

Family

ID=38777913

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11240A CR11240A (es) 2007-07-16 2010-01-27 Nuevos compuestos anti microbianos, su sintesis y su uso para el tratamiento de infecciones en mamiferos

Country Status (23)

Country Link
US (1) US8440842B2 (es)
EP (2) EP2020406A1 (es)
JP (1) JP5502731B2 (es)
KR (1) KR101588064B1 (es)
CN (1) CN101809009B (es)
AP (1) AP2010005131A0 (es)
AT (1) ATE482939T1 (es)
AU (1) AU2008278056B2 (es)
BR (1) BRPI0813828A2 (es)
CA (1) CA2693088C (es)
CO (1) CO6321160A2 (es)
CR (1) CR11240A (es)
DE (1) DE602008002843D1 (es)
EA (1) EA017806B1 (es)
EC (1) ECSP109962A (es)
MA (1) MA31607B1 (es)
MX (1) MX2010000672A (es)
NI (1) NI201000012A (es)
NZ (1) NZ582620A (es)
TN (1) TN2010000023A1 (es)
UA (1) UA99300C2 (es)
WO (1) WO2009010163A1 (es)
ZA (1) ZA201000491B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2380886A1 (en) 2010-04-23 2011-10-26 Vadim A. Makarov Process for the preparation of 2-aminosubstituted 1,3-benzothiazine-4-ones
WO2012066518A1 (en) * 2010-11-19 2012-05-24 Ecole Polytechnique Federale De Lausanne (Epfl) 2-piperazin-1-yl-4h-1,3-benzothiazin-4-one derivatives and their use for the treatment of mammalian infections
EP2468746A1 (en) 2010-12-23 2012-06-27 The University of Queensland Benzothiazinone compounds and their use as anti-tuberculosis agents
CN102276598B (zh) * 2011-05-27 2014-11-05 四川大学 苯并噻嗪硫酮衍生物及其制备方法和用途
EP2570413A1 (en) 2011-09-15 2013-03-20 The University Of Queensland Benzothiazinone derivatives as anti-tuberculosis agents
CN103508980B (zh) * 2012-06-14 2016-07-06 四川大学 苯并噻嗪-4-酮衍生物及其制备方法和用途
US9708339B2 (en) * 2014-06-09 2017-07-18 University Of Notre Dame Du Lac 1,3-benzothiazinone, sulfoxide, and sulfone compounds with electrophilic substituent
DE102014012546A1 (de) * 2014-09-26 2016-03-31 Martin-Luther-Universität Halle-Wittenberg Antimykobakteriell wirksame Substanzen, Verfahren zu ihrer Herstellung und deren Verwendung
EP3072889A1 (en) 2015-03-23 2016-09-28 Ecole Polytechnique Federale De Lausanne (Epfl) 2-Homopiperazine-1-yl-4H-1,3-benzothiazine-4-one derivatives and process for the preparation of 2-(homo)piperazine 1,3-benzothiazine-4-one hydrochlorides
MX2018001038A (es) 2015-07-27 2018-11-09 6Th Wave Innovations Corp Esferas de polimericas con impresion molecular para extraccion de metales y usos de estas.
CN105294597B (zh) * 2015-11-03 2017-11-24 华东师范大学 苯并噻嗪类衍生物及其合成方法和应用
CN110312725B (zh) 2016-09-22 2022-03-11 莱比尼兹自然研究和感染生物学研究所协会汉斯诺尔研究所(Hki) 新型抗菌化合物，其在哺乳动物感染治疗中的应用及新的代谢机制
BR112019009018A2 (pt) * 2016-11-03 2019-09-10 6Th Wave Innovations Corp esferas de polímero de impressão molecular para extração de lítio, mercúrio e escândio
CN108929329B (zh) * 2017-05-24 2020-12-11 中国医学科学院药物研究所 2-氮杂环-5-三氟甲基-8-硝基苯并(硫代)吡喃-4-酮类化合物
CN108947952B (zh) * 2017-05-24 2021-09-21 中国医学科学院药物研究所 2-取代氨基-5-三氟甲基-8-硝基苯并（硫代）吡喃-4-酮类化合物及其制备方法和用途
CN111269197A (zh) * 2020-04-08 2020-06-12 苏州大学 苯并噻嗪酮化合物及其制备方法与作为抗结核药物的应用
CN111303075A (zh) * 2020-04-08 2020-06-19 苏州大学 苯并噻嗪酮衍生物及其制备方法与作为抗结核药物的应用
WO2022204902A1 (zh) * 2021-03-29 2022-10-06 苏州大学 6- 位三氟甲基取代的苯并噻嗪酮衍生物及其制备方法与应用
WO2023065182A1 (zh) * 2021-10-20 2023-04-27 苏州大学 一种基于炔基连接臂的苯并噻嗪酮衍生物及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3522247A (en) * 1967-11-07 1970-07-28 Pfizer & Co C 2-amino-6,7-disubstituted-4h-1,3-benzothiazine-4-ones as bronchodilators
US5690598A (en) * 1996-09-27 1997-11-25 Liang; Yung Jen Wrist exerciser
US7659267B2 (en) * 2002-12-05 2010-02-09 Takeda Pharmaceutical Company Limited 1,3-Benzothiazinone derivatives, process for producing the same use thereof
US20090093468A1 (en) * 2004-03-26 2009-04-09 Patrizia Cali Peptide Deformylase Inhibitors
KR101314999B1 (ko) * 2006-05-24 2013-10-04 라이브니츠 인스티튜트 포 내추럴 프로덕트 리서치 앤드 인펙션 바이올로지 이.브이. 한스-크뇔-인스티튜트 (에이치케이아이) 신규한 벤조티아지논 유도체 및 그의 항균제로서의 용도

Also Published As

Publication number Publication date
CO6321160A2 (es) 2011-09-20
BRPI0813828A2 (pt) 2015-01-06
KR20100043071A (ko) 2010-04-27
UA99300C2 (ru) 2012-08-10
JP5502731B2 (ja) 2014-05-28
EP2176248B1 (en) 2010-09-29
US8440842B2 (en) 2013-05-14
DE602008002843D1 (de) 2010-11-11
CA2693088C (en) 2016-08-30
AU2008278056A1 (en) 2009-01-22
AU2008278056B2 (en) 2013-09-26
WO2009010163A1 (en) 2009-01-22
MX2010000672A (es) 2010-05-17
EP2176248A1 (en) 2010-04-21
CN101809009A (zh) 2010-08-18
CN101809009B (zh) 2013-04-24
JP2010533661A (ja) 2010-10-28
US20100286130A1 (en) 2010-11-11
KR101588064B1 (ko) 2016-01-22
ATE482939T1 (de) 2010-10-15
ZA201000491B (en) 2010-10-27
ECSP109962A (es) 2010-03-31
NZ582620A (en) 2012-03-30
AP2010005131A0 (en) 2010-02-28
EA201070145A1 (ru) 2010-06-30
NI201000012A (es) 2010-05-14
CA2693088A1 (en) 2009-01-22
EA017806B1 (ru) 2013-03-29
EP2020406A1 (en) 2009-02-04
TN2010000023A1 (en) 2011-09-26
MA31607B1 (fr) 2010-08-02

Similar Documents

Publication Publication Date Title
CR11240A (es) Nuevos compuestos anti microbianos, su sintesis y su uso para el tratamiento de infecciones en mamiferos
CY1121175T1 (el) Καταστολη οργανισμων βιο-μεμβρανης
GT200900230A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
DOP2012000299A (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
UY31228A1 (es) Ariloxazoles sustituidos y su uso
GT200800250A (es) Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
DOP2011000285A (es) 2-acetamido-5-aril-1, 2, 4-triazolonas sustituidas y su uso
NI201000015A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
HN2012000973A (es) INHIBIDORES DE N1-PIRAZOLOESPIROCETONA ACETIL-CoA CARBOXILASA
CU20120042A7 (es) (heteroarilmetil)tiohidantoínas sustituidas como drogas anticáncer
AR068369A1 (es) Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina"
BR112012018170A2 (pt) métodos de uso e agentes antimicrobianos.
CL2008001024A1 (es) Compuestos derivados de ftalazinona; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de enfermedades cardiovasculares, parkinson, enfermedades inflamatorias, esclerosis multiple, cancer, entre otras
HN2010002518A (es) Composicion farmaceutica que comprende una sal de estroncio, vitamina d y una ciclodextrina
GT200900266A (es) Nuevos compuestos heterociclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos
CR20140005A (es) Una nueva composición terapéutica que contiene apomorfina como principio activo
PA8784301A1 (es) Oxazolidinonas sustituidas y su uso
HN2010000128A (es) Imidazoles sustituidos con heterociclilamida
AR053775A1 (es) Nonadepsipeptidos acilados ii
BR112012008649A2 (pt) Composição farmacêutica e usos da referida composição
BR112012033612A2 (pt) riminofenazinas com substituintes de 2-(heteroaril)amino e sua atividade antimicrobiana
PA8814801A1 (es) Triazolopiridazinas como inhibidores de par1, su preparación y su uso como medicamentos
ATE437624T1 (de) Topische zusammensetzungen
EA201070251A1 (ru) Лекарственное средство в форме порошка для назальной доставки аскорбиновой кислоты для снижения токсичности в отношении реснитчатой ткани, индуцированной апоморфином

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)